Paxlovid Boceprevir Intermediate CAS 565456-77-1 Assay ≥99.0%

ʻO ka wehewehe pōkole:

Inoa: (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride

CAS: 565456-77-1

Ke 'ano: Pada ke'oke'o i ka pauka ke'oke'o

ʻIke: ≥99.0%

Kūwaena o PF-07321332 Paxlovid (CAS 2628280-40-8) a me Boceprevir (CAS 394730-60-0)

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride
Nā huaʻōlelo like Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride
Helu CAS 565456-77-1
Helu CAT RF-PI318
Kūlana Kūʻai Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala C9H15NO2.ClH
Kaumaha Molecular 205.683
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Keʻokeʻo a hiki i ka pauda keʻokeʻo
ʻIkepili A IR: E like me ka mea kuhikuhi
ʻIkepili B Manawa Hoʻopaʻa: E like me ka mea kuhikuhi
Enantiomer ≤0.15%
Ka haumia pili (na HPLC)
He haumia ʻike ʻole ≤0.20%
Huina paumaele ≤1.0%
Wai ≤0.50%
Koena ma ka Ignition ≤0.10%
Nā Metala Kaumaha ≤20ppm
Hoʻāʻo ≥99.0%
Kūlana hoʻāʻo Kūlana ʻoihana
Hoʻohana Kūwaena o PF-07321332 Paxlovid (CAS 2628280-40-8) a me Boceprevir (CAS 394730-60-0)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

1

FAQ:

Noi:

(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) he azabicyclohexane derivative i hoʻohana ʻia i ka hoʻomākaukau ʻana i ka hepatitis C. mea hoʻomaʻi (HCV) NS3 serine protease inhibitor.ʻO ia ka waena o PF-07321332 Paxlovid (CAS 2628280-40-8) a me Boceprevir (CAS 394730-60-0).ʻO PF-07321332 kahi mea hoʻomake a me ka waha i ka SARS-CoV 3C-like protease (3CLPRO) inhibitor.Kuhi ʻia ʻo PF-07321332 i ka maʻi SARS-CoV-2 a hiki ke hoʻohana ʻia no COVID-19 reseacrch.ʻO Boceprevir (INN, inoa kalepa ʻo Victrelis) he mea hoʻopaneʻe protease i hoʻohana ʻia ma ke ʻano he lapaʻau no ka maʻi hepatitis C genotype 1. Hoʻopaʻa ʻo ia i ka HCV nonstructural 3 NS3 (HCV) kahua ikaika.Ke kūkulu ʻia nei e Schering-Plough, akā ke kūkulu ʻia nei e Merck mai ka wā i loaʻa ai ʻo Schering i ka makahiki 2009. Ua ʻae ʻia e ka FDA ma Mei 13, 2011.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou